{"_links": {"parentPackage": {"href": "/mdr/ct/packages/sdtmct-2019-03-29", "title": "SDTM Controlled Terminology Package 37 Effective 2019-03-29", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/sdtmct-2018-12-21/codelists/C123650", "title": "CDISC SDTM Tumor and Lesion Identification Test Result Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/sdtmct/codelists/C123650", "title": "Version-agnostic anchor resource for codelist C123650", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/sdtmct-2019-03-29/codelists/C123650", "title": "CDISC SDTM Tumor and Lesion Identification Test Result Terminology", "type": "Code List"}}, "conceptId": "C123650", "definition": "Terminology relevant to tumor or lesion identification test results.", "extensible": "true", "name": "Tumor or Lesion Identification Test Results", "preferredTerm": "CDISC SDTM Tumor and Lesion Identification Test Result Terminology", "submissionValue": "TUIDRS", "synonyms": ["Tumor or Lesion Identification Test Results"], "terms": [{"conceptId": "C48190", "definition": "Not existing in a specified place at a specified time. (NCI)", "preferredTerm": "Absent", "submissionValue": "ABSENT"}, {"conceptId": "C14172", "definition": "For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health. (NCI)", "preferredTerm": "Benign", "submissionValue": "BENIGN", "synonyms": ["Benign"]}, {"conceptId": "C132466", "definition": "A localized pathological or traumatic structural change, damage, deformity, or discontinuity of the bone.", "preferredTerm": "Bone Lesion Identification", "submissionValue": "BONE LESION"}, {"conceptId": "C25321", "definition": "Of or belonging to an area on the body that is far apart in relation to a point of origin.", "preferredTerm": "Distant", "submissionValue": "DISTANT"}, {"conceptId": "C67263", "definition": "Of or belonging to a restricted area on the body in relation to a point of origin.", "preferredTerm": "Local", "submissionValue": "LOCAL"}, {"conceptId": "C25388", "definition": "Of or belonging to either a local and/or regional area of the body in relation to a point of origin.", "preferredTerm": "Local-Regional", "submissionValue": "LOCOREGIONAL"}, {"conceptId": "C103416", "definition": "The identification of a tumor, lesion, or site of disease that is present at baseline and will be quantifiably measured.", "preferredTerm": "Measured Tumor Identification", "submissionValue": "MEASURED"}, {"conceptId": "C94522", "definition": "The identification of a tumor, lesion, or site of disease which has not been previously seen or characterized.", "preferredTerm": "New Lesion Identification", "submissionValue": "NEW"}, {"conceptId": "C132467", "definition": "A localized pathological or traumatic structural change, damage, deformity, or discontinuity of the bone, which has not been previously seen or characterized.", "preferredTerm": "New Bone Lesion Lesion Identification", "submissionValue": "NEW BONE LESION"}, {"conceptId": "C139126", "definition": "The identification of a tumor, lesion, or site of disease that will be assessed qualitatively over time, and which was not detected at baseline.", "preferredTerm": "New Non-Target Lesion Identification", "submissionValue": "NEW NON-TARGET", "synonyms": ["New Non-Index"]}, {"conceptId": "C139127", "definition": "The identification of a tumor, lesion, or site of disease that will be assessed quantitatively over time, and which was not detected at baseline.", "preferredTerm": "New Target Lesion Identification", "submissionValue": "NEW TARGET", "synonyms": ["New Index"]}, {"conceptId": "C103423", "definition": "The identification of a tumor, lesion, or site of disease that is incapable of being measured at baseline.", "preferredTerm": "Non-Measurable Tumor Identification", "submissionValue": "NON-MEASURABLE"}, {"conceptId": "C94521", "definition": "The identification of a tumor, lesion or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention.", "preferredTerm": "Non-Target Lesion Identification", "submissionValue": "NON-TARGET", "synonyms": ["Non-Index"]}, {"conceptId": "C132468", "definition": "The identification of a contrast-enhancing tumor, lesion, or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention.", "preferredTerm": "Non-target Enhancing Lesion Identification", "submissionValue": "NON-TARGET ENHANCING"}, {"conceptId": "C132469", "definition": "The identification of a tumor or lesion located outside of or independent of any lymph nodes that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention.", "preferredTerm": "Non-Target Extra Nodal Lesion Identification", "submissionValue": "NON-TARGET EXTRA NODAL"}, {"conceptId": "C132470", "definition": "The identification of a tumor or lesion located at or near the lymph node that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention.", "preferredTerm": "Non-Target Nodal Lesion Identification", "submissionValue": "NON-TARGET NODAL"}, {"conceptId": "C132471", "definition": "The identification of a non-contrast-enhancing tumor, lesion, or site of disease that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention.", "preferredTerm": "Non-target Non-enhancing Lesion Identification", "submissionValue": "NON-TARGET NON-ENHANCING"}, {"conceptId": "C103425", "definition": "The identification of a tumor, lesion, or site of disease that is present at baseline and will not be quantifiably measured.", "preferredTerm": "Not Measured Tumor Identification", "submissionValue": "NOT MEASURED"}, {"conceptId": "C150897", "definition": "The identification of an organ that may contain a tumor, lesion or site of disease, and is part of the assessment of the response to the therapeutic intervention.", "preferredTerm": "Organ of Interest", "submissionValue": "ORGAN OF INTEREST"}, {"conceptId": "C25643", "definition": "Of or belonging to a broader area or region of the body in relation to a point of origin.", "preferredTerm": "Regional", "submissionValue": "REGIONAL"}, {"conceptId": "C94520", "definition": "The identification of a tumor, lesion, or site of disease that is present at baseline and is the target of the therapeutic intervention.", "preferredTerm": "Target Lesion Identification", "submissionValue": "TARGET", "synonyms": ["Index"]}, {"conceptId": "C103442", "definition": "The identification of a tumor or lesion that is present at baseline, located outside of or independent of any lymph nodes, and is the target of the therapeutic intervention.", "preferredTerm": "Target Extra Nodal Tumor Identification", "submissionValue": "TARGET EXTRA NODAL"}, {"conceptId": "C103443", "definition": "The identification of a tumor or lesion located at or near the lymph node that is present at baseline and is the target of the therapeutic intervention.", "preferredTerm": "Target Nodal Tumor Identification", "submissionValue": "TARGET NODAL"}, {"conceptId": "C103444", "definition": "The identification of a nodule that is the target of the therapeutic intervention.", "preferredTerm": "Target Nodule Tumor Identification", "submissionValue": "TARGET NODULE"}]}